Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kevin Martin

Orthopaedic Surgery Gahanna, OH Doctor of Osteopathy

NPI 1659535912 CMS profile 1065233

920 N Hamilton Rd Ste 600, Gahanna, OH 43230

Open in the dashboard

General payments

$403,903

433 records reported · program years 2019–2025

Research payments

$11,500

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$53,692 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Kevin Martin of Gahanna, OH is reported in the CMS Open Payments database as having received $403,903 across 433 general payments and $11,500 in research payments paid to them. Separately, studies naming them as principal investigator received $53,692 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $175,752 102
2025 Research $11,125 1
2024 General $70,974 90
2024 Research $375 1
2023 General $67,512 96
2022 General $45,512 49
2021 General $30,231 45
2020 General $3,980 17
2019 General $9,942 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kevin Martin
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Kevin Martin were reported at $175,752. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Kevin Martin Orthopaedic Surgery median Middle half National median
2019 $9,942 $644 $140–$2,844 $163
2020 $3,980 $312 $75–$1,860 $114
2021 $30,231 $520 $117–$2,495 $132
2022 $45,512 $598 $128–$2,731 $149
2023 $67,512 $461 $128–$2,264 $160
2024 $70,974 $497 $134–$2,475 $164
2025 $175,752 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $358,340 355 payments
  2. Linvatec Corporation $32,482 31 payments
  3. Musculoskeletal Transplant Foundation Inc. $5,607 3 payments
  4. CDC Medical LLC $4,920 12 payments
  5. Gemini Mountain Medical, LLC $1,311 6 payments
  6. Cosa Medical, LLC $505 10 payments
  7. Stryker Corporation $295 7 payments
  8. Titan Surgical Group, LLC $136 2 payments
  9. Pinnacle, Inc $114 1 payment
  10. Djo, LLC $65 1 payment
  11. Other $128 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $237,640 107 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $125,394 53 payments
  3. Travel and Lodging $24,678 100 payments
  4. Food and Beverage $7,934 163 payments
  5. Education $6,561 7 payments
  6. Royalty or License $1,697 3 payments
Products named General payments · program years 2019–2025
  1. ALLOGRAFT TISSUE $9,308 12 payments
  2. BIOBRACE 23MM $8,879 6 payments
  3. LINVATEC EXTREMITIES $7,117 7 payments
  4. CARTIMAX $7,073 5 payments
  5. DISTAL EXTREMITIES INSTRUMENTS TRAUMA HINDFOOT & ANKLE TRAUMA $1,488 1 payment
  6. EXTREMITIES & TRAUMA IMPLANTS SOFT TISSUE IB LIGAMENT AUGMENTATION $1,188 1 payment
  7. EXTREMITIES & TRAUMA IMPLANTS SOFT TISSUE ANCHORS $1,188 1 payment
  8. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE SPEEDBRIDGE $713 1 payment
  9. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ACHILLES $713 1 payment
  10. DISTAL EXTREMITIES IMPLANTS IB LIGAMENT AUGMENTATION OTHER $213 1 payment
  11. Other $1,402 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Arthrex, Inc. $11,500 2 payments

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$32,042

Medicare's payments for the services billed

Medicare patients

126

Average age 68

Services billed

279

74 women, 52 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 69%
Ischemic heart disease 32%
Diabetes 24%
Depression 23%
Osteoporosis 21%
Atrial fibrillation 14%
COPD 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

435 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record